For example, the (pre) clinical results of other neoangiogenesis-based tracers, like cRGD-peptide- (αvβ3 integrin) and vascular endothelial growth factor (VEGF)-targeting antibodies demonstrate efficient whole-tumor imaging [31,32]. Here, VEGFA is linked to neoplasm.